Home›Research›Compare›FGF-1 vs Sigumir
Peptide ComparisonFGF-1 vs Sigumir
Both are Skin & Cosmetic peptides.
FGF-1
Fibroblast Growth Factor 1
No providers listed yet
Sigumir
Val-Glu-Pro-Arg
Half-life: Unknown
1 providers listed
FGF-1 carries stronger published evidence (RCT, 1 key studies) than Sigumir (Review, 2); both are research compounds.
FGF-1
Evidence
Sigumir
Evidence
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | FGF-1 |
| Oral administration option | Sigumir |
| More provider options (0 vs 1) | Sigumir |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
FGF-1
Sigumir
About FGF-1
Binds all four FGFR subtypes (broadest binding of FGF family). Activates MAPK and PI3K downstream pathways. Promotes fibroblast proliferation, angiogenesis, and hair follicle cycling into anagen phase.
About Sigumir
Tetrapeptide bioregulator targeting joint and bone tissue; modulates osteoblast and chondrocyte activity; reduces local joint inflammation; promotes extracellular matrix production
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
FGF-1
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Sigumir
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Skin & Cosmetic Comparisons
Browse all peptides →Educational research tools — not medical advice.